1-4 of 4
Anna Franceschino
Close
Sort by
Journal Articles

The Nup98-HoxA9 Leukemogenic Fusion Protein Blocks Xpo1 and Tap-Mediated Nuclear Export

Yildirim Dogan, PhD, Sutapa Sahay, PhD, David C Dorn, MD, Anna Franceschino, MD, Michael Xu, Malcolm A.S. Moore, D.Phil
Journal: Blood
Blood (2011) 118 (21): 5228.
https://doi.org/10.1182/blood.V118.21.5228.5228
Published: 2011
Journal Articles

Imatinib concentrations in human milk

Carlo B. Gambacorti-Passerini, Lucia Tornaghi, Elena Marangon, Anna Franceschino, Enrico M. Pogliani, Maurizio D'Incalci, Massimo Zucchetti
Journal: Blood
Blood (2007) 109 (4): 1790.
https://doi.org/10.1182/blood-2006-10-051391
Published: 2007
Journal Articles

In Vitro and In Vivo Activity of SKI-606, a Novel Abl/Src Inhibitor, Against Imatinib Resistant BCR-ABL+ Neoplastic Cells.

Miriam Puttini, Addolorata M.L. Coluccia, Frank Boschelli, Anna Franceschino, Lucia Tornaghi, Shaheen Ahmed, Sara Redaelli, Rocco Piazza, Vera Magistroni, Federica Andreoni, Leonardo Scapozza, Franca Formelli, Carlo Gambacorti
Journal: Blood
Blood (2006) 108 (11): 2176.
https://doi.org/10.1182/blood.V108.11.2176.2176
Published: 2006
Journal Articles

Bim Promoter Is Highly Methylated in Malignant Lymphoid Cell Lines, Leading to Downregulation of Bim Expression and Protection from Apoptosis.

Rocco G. Piazza, MD, PhD, Vera Magistroni, Federica Andreoni, Anna Franceschino, MD, Carlo Gambacorti, MD
Journal: Blood
Blood (2005) 106 (11): 2625.
https://doi.org/10.1182/blood.V106.11.2625.2625
Published: 2005